Aberrant FcγRIIb and FcγRIII expression on monocytes from patients with Behçet's disease.
暂无分享,去创建一个
Xin Yu | Fengchun Zhang | Xuan Zhang | Hua Chen | Wenjie Zheng | Linfang Huang | Wanli Liu | Jinjing Liu | Lu Li | Xiuhua Wu | Xiangping Liao | Yan Zeng
[1] C. Hedrick,et al. Nonclassical Monocytes in Health and Disease. , 2019, Annual review of immunology.
[2] A. Kijlstra,et al. Analysis of the association between Fc receptor family gene polymorphisms and ocular Behçet’s disease in Han Chinese , 2018, Scientific Reports.
[3] Sitaram Vangala,et al. Comparative Immunogenicity of TNF Inhibitors: Impact on Clinical Efficacy and Tolerability in the Management of Autoimmune Diseases. A Systematic Review and Meta-Analysis , 2015, BioDrugs.
[4] Hongchao Qin,et al. Immune complex negatively regulates Toll‐like receptor 9‐mediated immune responses in B cells through the inhibitory Fc‐gamma receptor IIb , 2015, Microbiology and immunology.
[5] E. Wennerberg,et al. Dysregulated Fc receptor function in active rheumatoid arthritis. , 2014, Immunology letters.
[6] R. Blumberg,et al. The Role of FcRn in Antigen Presentation , 2014, Front. Immunol..
[7] I. Olivieri,et al. The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria , 2014 .
[8] Y. Saeys,et al. The function of Fcγ receptors in dendritic cells and macrophages , 2014, Nature Reviews Immunology.
[9] L. Ginaldi,et al. An Update on Autoinflammatory Diseases , 2013, Current medicinal chemistry.
[10] A. Hedayatfar. Behçet’s Disease: Autoimmune or Autoinflammatory? , 2013, Journal of ophthalmic & vision research.
[11] C. Melief,et al. Fcγ Receptor IIb Strongly Regulates Fcγ Receptor-Facilitated T Cell Activation by Dendritic Cells , 2012, The Journal of Immunology.
[12] P. Matt,et al. Down regulation of Fc and complement receptors on B cells in rheumatoid arthritis. , 2010, Clinical immunology.
[13] J. W. Booth,et al. Divergent Intracellular Sorting of FcγRIIA and FcγRIIB2* , 2010, The Journal of Biological Chemistry.
[14] E. Alpsoy,et al. IL-17A has an important role in the acute attacks of Behçet's disease. , 2010, The Journal of investigative dermatology.
[15] M. Segal,et al. Monocyte surface expression of Fcγ receptor RI (CD64), a biomarker reflecting type-I interferon levels in systemic lupus erythematosus , 2010, Arthritis research & therapy.
[16] Kenneth G. C. Smith,et al. FcγRIIB in autoimmunity and infection: evolutionary and therapeutic implications , 2010, Nature Reviews Immunology.
[17] J. Aguillón,et al. B cells from rheumatoid arthritis patients show important alterations in the expression of CD86 and FcγRIIb, which are modulated by anti-tumor necrosis factor therapy , 2010, Arthritis research & therapy.
[18] T. Niki,et al. Galectin-9 ameliorates immune complex-induced arthritis by regulating Fc gamma R expression on macrophages. , 2009, Clinical immunology.
[19] Xinrui Li,et al. Fcγ receptors: structure, function and role as genetic risk factors in SLE , 2009, Genes and Immunity.
[20] M. Segal,et al. Increased expression of FcγRI/CD64 on circulating monocytes parallels ongoing inflammation and nephritis in lupus , 2009, Arthritis Research & Therapy.
[21] Yan Zhang,et al. Immune Complex/Ig Negatively Regulate TLR4-Triggered Inflammatory Response in Macrophages through FcγRIIb-Dependent PGE2 Production1 , 2009, The Journal of Immunology.
[22] K. Aksu,et al. FcgammaRIIa, IIIa and IIIb gene polymorphisms in Behçet's disease: do they have any clinical implications? , 2008, Clinical and experimental rheumatology.
[23] A. Kijlstra,et al. Upregulated IL-23 and IL-17 in Behçet patients with active uveitis. , 2008, Investigative ophthalmology & visual science.
[24] Kenneth G. C. Smith,et al. Distinct cell-specific control of autoimmunity and infection by FcγRIIb , 2008, The Journal of experimental medicine.
[25] J. Salmon,et al. Infliximab treatment shifts the balance between stimulatory and inhibitory Fcgamma receptor type II isoforms on neutrophils in patients with rheumatoid arthritis. , 2008, Arthritis and rheumatism.
[26] J. Ravetch,et al. Fcγ receptors as regulators of immune responses , 2008, Nature Reviews Immunology.
[27] R. Kimberly,et al. Expression Profile of FcγRIIb on Leukocytes and Its Dysregulation in Systemic Lupus Erythematosus1 , 2007, The Journal of Immunology.
[28] S. Luo,et al. Association of rheumatoid factor production with FcγRIIIa polymorphism in Taiwanese rheumatoid arthritis , 2006, Clinical and experimental immunology.
[29] C. Sautès-Fridman,et al. Differential Modulation of Stimulatory and Inhibitory Fcγ Receptors on Human Monocytes by Th1 and Th2 Cytokines1 , 2001, The Journal of Immunology.
[30] M. K. Kim,et al. Fc gamma receptors differ in their structural requirements for interaction with the tyrosine kinase Syk in the initial steps of signaling for phagocytosis. , 2001, Clinical immunology.
[31] J. Martín,et al. Involvement of Fcgamma receptor IIIA genotypes in susceptibility to rheumatoid arthritis. , 2000, Arthritis and rheumatism.
[32] M. Daëron,et al. Fc receptor biology. , 2003, Annual review of immunology.
[33] R. Kimberly,et al. A novel polymorphism of FcgammaRIIIa (CD16) alters receptor function and predisposes to autoimmune disease. , 1997, The Journal of clinical investigation.
[34] P. Budde,et al. Tyrosine-containing sequence motifs of the human immunoglobulin G receptors FcRIIb1 and FcRIIb2 essential for endocytosis and regulation of calcium flux in B cells. , 1994, The Journal of biological chemistry.